Oy Vey! Israel's Generic King Teva to Pay $7.5 Billion for Barr Pharmaceuticals, an Industrial Info News Alert SUGAR LAND, TX--(MARKET WIRE)--Jul 21, 2008 -- Reported by Annette Kreuger, Industrial Info
Resources (Sugar Land, Texas) -- Teva Pharmaceutical Industries
Limited
(TEVA - News) (Jerusalem, Israel) has made a $7.46 billion
agreement to
purchase Barr Pharmaceuticals Incorporated (NYSE:BRL - News) (Woodcliff
Lake, New
Jersey). Already the world's largest generic producer, the
acquisition of
Barr, the world's fourth largest generic company, will serve
to solidify
Teva's place at the top. The transaction is expected to
be complete by the
end of 2008. According to a statement by Teva, if the two
companies had
been operating as one in 2007, the combined revenue would
have been close
to $12 billion. When Barr is absorbed into Teva, the company
will have
operations in more than 60 countries and employ about 37,000
people
worldwide. For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showNews.jsp?newsitemID=135704, or browse other breaking industrial news stories at www.industrialinfo.com. Industrial Info Resources (IIR) is a marketing information service specializing in industrial process, energy and financial related markets with products and services ranging from industry news, analytics, forecasting, plant and project databases, as well as multimedia services. For more information send inquiries to pharmabiogroup@industrialinfo.com or visit us at www.industrialinfo.com. Related News Articles Pharmaceutical-Biotech Construction Update: 31 New Facilities Open Doors in First Half of 2008 Contact: Contact:
Joe Govreau
713-783-5147
Source: Industrial Info Resources
|  |
